D-0352-2021 Class II Ongoing
FDA drug recall D-0352-2021 was initiated by S & B Story LLC on Mar 25, 2021 and is designated Class II. Reason for recall: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- May 5, 2021
- Initiation Date
- Mar 25, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Imperial Extreme 2000 Capsules, 2000 mg, 1 count blister cards, distributed S&B Shopper LLC. Little Ferry, NJ UPC 7 18122 04073 5
Reason for recall
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Distribution pattern
Nationwide
Code information
all lots and expirys
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0352-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026